LAS VEGAS (PRWEB) April 30, 2018
ExosomeLife has developed a new way of establishing clinical-grade exosome banks under its trademark ExoBank™ by making breakthroughs in proprietary methods to manufacture, purify and engineer exosomes in a more efficient, faster, and much less costly manner.
ExosomeLife has developed a method to increase the stability of exosomes and keep their potencies over long periods of time using its ExoBank™ proprietary methodology. The ExoBank™ methodology would have the capacity to store clinical-grade, quality-controlled exosomes for extended periods of time for therapeutic purposes.
About ExosomeLife LLC
ExosomeLife LLC is a privately held biotechnology company dedicated to creating next generation therapeutics for patients through its patent-applied-for and proprietary platform of ExoIntel™ and through its breakthrough technology of storage using its ExoBank™ platform. ExosomeLife is determined to bring economic cures and treatments for diseases that impair quality of life for millions of people around the globe.
+1 (702) 722-7177